Molecular diagnosis of sex chromosome mosaics in fetal amniotic cells.

ABSTRACT: Mosaicism can be observed in karyotype analyses of amniotic fluid cells. Differentiating between true mosaicism and pseudomosaicism and determining mosaic proportions can help avoid misjudgments by doctors and effectively reduce mental and physical harm to pregnant women. However, the detection of mosaicism and mosaic proportions via karyotype analysis and fluorescence in situ hybridization (FISH) is extremely complex. We have developed a novel approach, "segmental duplication quantitative fluorescent PCR" (SD-QF-PCR), to detect mosaicism and mosaic proportions.In this study, twenty control samples and fourteen mosaic samples were tested by first-line karyotype analysis; by second-line karyotype analysis, SD-QF-PCR and FISH were used to reassess fetal sex chromosome mosaicism and mosaic proportions.Detection of the 20 control samples by second-line karyotype analysis via FISH and SD-QF-PCR showed normal and consistent results. Among the 14 mosaic samples, the numbers of samples showing true mosaicism and pseudomosaicism detected by the three methods were 6 and 8, respectively.Our study demonstrates that SD-QF-PCR can be used as a complementary method to traditional cytogenetic analysis of amniotic fluid mosaics and has clinical application value.

Enhancing the Structural Stability of Ni-Rich Layered Oxide Cathodes with a Preformed Zr-Concentrated Defective Nanolayer.

Nickel-rich layered oxides (NLOs) exhibit great potential to meet the ever-growing demand for further increases in the energy density of Li-ion batteries because of their high specific capacities. However, NLOs usually suffer from severe structural degradation and undesired side reactions when cycled above 4.3 V. These effects are strongly correlated with the surface structure and chemistry of the active NLO materials. Herein, we demonstrate a preformed cation-mixed ( Fm3̅ m) surface nanolayer (∼5 nm) that shares a consistent oxygen framework with the layered lattice through Zr modification, in which Ni cations reside in Li slabs and play the role of a "pillar". This preformed nanolayer alleviates the detrimental phase transformations upon electrochemical cycling, effectively enhancing the structural stability. As a result, the Zr-modified Li(Ni0.8Co0.1Mn0.1)0.985Zr0.015O2 material exhibits a high reversible discharge capacity of ∼210 mA h/g at 0.1 C (1 C = 200 mA/g) and outstanding cycling stability with a capacity retention of 93.2% after 100 cycles between 2.8 and 4.5 V. This strategy may be further extended to design and prepare other high-performance layered oxide cathode materials.

Electrochemical Property-Structure Correlation for Ni-Based Layered Na-Ion Cathodes.

A class of Ni-based layered Na xNi0.5Mn0.3Co0.2O2 oxide composites is prepared via a solid-state process. Mixed P-, O-, and P-/O-type phases can be obtained by tuning the Na content and annealing temperature, as demonstrated by structural and chemical characterization. Among these materials, the triphase P2/P'3/O'3-type composite exhibits the best overall electrochemical performance. Specifically, this triphase composite delivers a high specific capacity of 126 mA h g-1 in the potential range of 1.5-4.2 V, high rate capability (∼72% of its initial capacity at a rate of 5 C), and good capacity retention after 100 cycles at 0.5 C. The structural transition mechanism for each phase upon electrochemical cycling is investigated, providing insights into the correlation between electrochemical properties and the crystal structure of Ni-rich layered Na xNi0.5Mn0.3Co0.2O2 oxide composites.

P-glycoprotein Mediates Postoperative Peritoneal Adhesion Formation by Enhancing Phosphorylation of the Chloride Channel-3.

P-glycoprotein (P-gp) is encoded by the multidrug resistance (MDR1) gene and is well studied as a multi-drug resistance transporter. Peritoneal adhesion formation following abdominal surgery remains an important clinical problem. Here, we found that P-gp was highly expressed in human adhesion fibroblasts and promoted peritoneal adhesion formation in a rodent model. Knockdown of P-gp expression by intraperitoneal injection of MDR1-targeted siRNA significantly reduced both the peritoneal adhesion development rate and adhesion grades. Additionally, we found that operative injury up-regulated P-gp expression in peritoneal fibroblasts through the TGF-ß1/Smad signaling pathway and histone H3 acetylation. The overexpression of P-gp accelerated migration and proliferation of fibroblasts via volume-activated Cl(-) current and cell volume regulation by enhancing phosphorylation of the chloride channel-3. Therefore, P-gp plays a critical role in postoperative peritoneal adhesion formation and may be a valuable therapeutic target for preventing the formation of peritoneal adhesions.

Chloride channel-3 promotes tumor metastasis by regulating membrane ruffling and is associated with poor survival.

The chloride channel-3 (ClC-3) protein is known to be a component of Cl- channels involved in cell volume regulation or acidification of intracellular vesicles. Here, we report that ClC-3 was highly expressed in the cytoplasm of metastatic carcinomatous cells and accelerated cell migration in vitro and tumor metastasis in vivo. High-grade expression of cytoplasmic ClC-3 predicted poor survival in cancer patients. We found that independent of its volume-activated Cl- channel properties, ClC-3 was able to promote cell membrane ruffling, required for tumor metastasis. ClC-3 mediated membrane ruffling by regulating keratin 18 phosphorylation to control ß1 Integrin recycling. Therefore, cytoplasmic ClC-3 plays an active and key role in tumor metastasis and may be a valuable prognostic biomarker and a therapeutic target to prevent tumor spread.

Cell cycle-dependent subcellular distribution of ClC-3 in HeLa cells.

Chloride channel-3 (ClC-3) is suggested to be a component and/or a regulator of the volume-activated Cl(-) channel in the plasma membrane. However, ClC-3 is predominantly located inside cells and the role of intracellular ClC-3 in tumor growth is unknown. In this study, we found that the subcellular distribution of endogenous ClC-3 varied in a cell cycle-dependent manner in HeLa cells. During interphase, ClC-3 was distributed throughout the cell and it accumulated at various positions in different stages. In early G1, ClC-3 was mainly located in the nucleus. In middle G1, ClC-3 gathered around the nuclear periphery as a ring. In late G1, ClC-3 moved back into the nucleus, where it remained throughout S phase. In G2, ClC-3 was concentrated in the cytoplasm. When cells progressed from G2 to the prophase of mitosis, ClC-3 from the cytoplasm translocated into the nucleus. During metaphase and anaphase, ClC-3 was distributed throughout the cell except for around the chromosomes and was aggregated at the spindle poles and in between two chromosomes, respectively. ClC-3 was then again concentrated in the nucleus upon the progression from telophase to cytokinesis. These results reveal a cell cycle-dependent change of the subcellular distribution of ClC-3 and strongly suggest that ClC-3 has nucleocytoplasmic shuttling dynamics that may play key regulatory roles during different stages of the cell cycle in tumor cells.